Updated phase I trial of anti-LAG-3 or anti-CD137 alone and in combination with anti-PD-1 in patients with recurrent GBM Meeting Abstract


Authors: Lim, M.; Ye, X.; Piotrowski, A. F.; Desai, A. S.; Ahluwalia, M. S.; Walbert, T.; Fisher, J. D.; Desideri, S.; Belcaid, Z.; Jackson, C.; Nabors, L. B.; Wen, P. Y.; Grossman, S. A.
Abstract Title: Updated phase I trial of anti-LAG-3 or anti-CD137 alone and in combination with anti-PD-1 in patients with recurrent GBM
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Start Page: 91s
Language: English
ACCESSION: WOS:000487345804399
DOI: 10.1200/JCO.2019.37.15_suppl.2017
PROVIDER: wos
Notes: Meeting Abstract: 2017 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors